Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,138,312 papers from all fields of science
Search
Sign In
Create Free Account
Sjogren's Syndrome
Known as:
sjoegren's syndrome
, Sjogren Syndrome
, SYNDROME SJOGREN'S
Expand
An autoimmune disease that affects the tear glands and salivary glands, and may affect glands in the stomach, pancreas, and intestines. The disease…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
35 relations
Arthritis
Autosomal recessive inheritance
COMPLEMENT COMPONENT 2 DEFICIENCY
In Blood
Expand
Broader (4)
Autoimmune Diseases
Collagen Diseases
Keratoconjunctivitis Sicca
Syndrome
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
A BAFF Receptor His159Tyr Mutation in Sjögren's Syndrome–Related Lymphoproliferation
A. Papageorgiou
,
C. Mavragani
,
+7 authors
M. Voulgarelis
Arthritis & Rheumatology
2015
Corpus ID: 20964647
To study the prevalence, clinical associations, and functional implications of the His159Tyr mutation of the BAFF receptor (BAFF…
Expand
Review
2000
Review
2000
Approaches to the treatment of Sjögren's syndrome.
R. Fox
,
P. Michelson
Journal of Rheumatology Supplement
2000
Corpus ID: 21471467
Sjögren's syndrome (SS) is a systemic autoimmune disease characterized by complaints of sicca symptoms (dry eye and mouth) and…
Expand
Review
1996
Review
1996
Clinical features, pathogenesis, and treatment of Sjögren's syndrome.
Robert I. Fox
Current Opinion in Rheumatology
1996
Corpus ID: 45711333
Primary Sjögren's syndrome (SS) is a systemic autoimmune disease that is characterized by keratoconjunctivitis sicca and…
Expand
Review
1992
Review
1992
Anti-Ro in Sjögren's syndrome and systemic lupus erythematosus.
J. Harley
,
R. Scofield
,
M. Reichlin
Rheumatic Disease Clinics of North America
1992
Corpus ID: 22262967
Anti-Ro autoantibodies are frequently found in the sera of patients with Sjögren's syndrome, systemic lupus erythematosus, and…
Expand
Review
1991
Review
1991
CD5+ B cells in autoimmune disease and lymphoid malignancy.
T. Shirai
,
S. Hirose
,
T. Okada
,
H. Nishimura
Clinical Immunology and Immunopathology
1991
Corpus ID: 21531768
Highly Cited
1989
Highly Cited
1989
Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseases.
M. Manoussakis
,
G. Papadopoulos
,
A. Drosos
,
H. Moutsopoulos
Clinical Immunology and Immunopathology
1989
Corpus ID: 32374653
Highly Cited
1987
Highly Cited
1987
Vasculitis in primary Sjögren's syndrome. Histologic classification and clinical presentation.
M. Tsokos
,
S. Lazarou
,
H. Moutsopoulos
American Journal of Clinical Pathology
1987
Corpus ID: 40755016
Nine out of 70 patients with primary Sjögren's syndrome had vasculitis of small and/or medium-sized vessels. The small vessel…
Expand
Highly Cited
1987
Highly Cited
1987
Sjogren's Syndrome: Clinical and Immunological Aspects
N. Talal
,
H. Moutsopoulos
,
S. Kassan
1987
Corpus ID: 181393315
I. Introduction.- 1. Historical Perspective: The Early Years (1930-1960).- 2. The Patient's Perspective.- II. Clinical Spectrum…
Expand
Highly Cited
1981
Highly Cited
1981
Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and primary Sjögren's syndrome.
A. Fauci
,
H. Moutsopoulos
Arthritis & Rheumatism
1981
Corpus ID: 38238442
Numbers of B cells spontaneously secreting Ig (IgG, IgA, and IgM) were determined by a plaque-forming cell (PFC) assay…
Expand
Highly Cited
1977
Highly Cited
1977
Sjögren's Syndrome Associated with HLA-Dw3
T. Chused
,
S. Kassan
,
G. Opelz
,
H. Moutsopoulos
,
P. Terasaki
1977
Corpus ID: 76027671
Abstract Sjogren's syndrome is associated with a serologically defined histocompatibility antigen of the HLA-B locus, HLA-B8…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE